Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sympathetic neurons undergo protein synthesis-dependent apoptosis when deprived of nerve growth factor (NGF). Expression of
SM-20
is up-regulated in NGF-deprived sympathetic neurons, and ectopic
SM-20
is sufficient to promote neuronal death in the presence of NGF. We now report that
SM-20
is a mitochondrial protein that promotes cell death through a caspase-dependent mechanism.
SM-20
immunofluorescence was present in the cytoplasm in a punctate pattern that colocalized with cytochrome oxidase I and with mitochondria-selective dyes. Analysis of
SM-20
/
dihydrofolate reductase
fusion proteins revealed that the first 25 amino acids of
SM-20
contain a functional mitochondrial targeting sequence. An amino-terminal truncated form of
SM-20
was not restricted to mitochondria but instead localized throughout the cytosol and nucleus. Nevertheless, the truncated
SM-20
retained the ability to induce neuronal death, similar to the wild type protein.
SM-20
-induced death was accompanied by caspase-3 activation and was blocked by a general caspase inhibitor. Additionally, overexpression of
SM-20
, under conditions where cell death is blocked by a general caspase inhibitor, did not result in widespread release of cytochrome c from mitochondria. These results indicate that
SM-20
is a novel mitochondrial protein that may be an important mediator of neurotrophin-withdrawal-mediated cell death.
...
PMID:SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. 1106 Mar 9